Japan handles medical devices with multiple indications by evaluating each indication separately for reimbursement under the NHI system. MHLW & Chuikyo assess the clinical efficacy, safety, and cost-effectiveness for all approved indications. Pricing and classification may differ depending on the indication’s value, healthcare impact, and alignment with reimbursement criteria.
